You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

ACP Clinical Guidelines

ACP Clinical Practice Guidelines cover many areas of internal medicine, ranging from screening to diagnosis and treatment of disease. The evidence-based guidelines provide recommendations to help clinicians deliver the best health care possible.

ACP High Value Care Advice focuses on high value care that assist physicians to provide the best possible care to their patients while simultaneously reducing unnecessary costs to the healthcare system.

Download the ACP Clinical Guidelines App! Access ACP Guidelines from your smart phone or tablet. To download, visit ACP Guidelines App for iTunes or ACP Guidelines App for Android.

Recently Published

  1. Nonpharmacological Versus Pharmacological Treatment of Adult Patients with Major Depressive Disorder: A Clinical Practice Guideline from the American College of Physicians. Published March 1, 2016. Click here to access the full text.
  2. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Published May 3, 2016. Click here to access the full text.

Click here for all ACP Guidelines

Guidelines International Network 2016

27-30 September 2016

ACP is pleased to announce that it is co-hosting, alongside Penn Medicine and ECRI Institute, the 2016 annual meeting for the Guidelines International Network (G-I-N). The meeting will take place 27-30 September 2016 in Philadelphia, Pennsylvania, USA.

G-I-N’s mission is to lead, strengthen and support collaboration and research within the guideline community, and the annual conference provides an excellent opportunity for networking, learning, and sharing information.

The theme of this year’s G-I-N conference is “Individualised guidelines and clinical performance measurement in an era of personalised medicine.” We welcome all stakeholders, from public and health care providers to policy makers and insurers, to guideline developers, implementers, and researchers, performance measures developers and implementers, and anyone else with a vested interest in developing, promoting, adapting, or implementing guidelines and performance measures.

For more information, visit or follow us on Twitter: @GINConference

Back to the July International Newsletter